Neisseria meningitidis is a human-only pathogen that thrives by constantly rewriting its own genome.

Neisseria meningitidis is a human-only pathogen that thrives by constantly rewriting its own genome.
Image: Intellect (generated)

In short: This round bacterium, often living harmlessly in the human throat, can suddenly turn lethal, causing meningitis or rapid-onset sepsis. It survives by stealing iron from human proteins and using a sophisticated mechanism of genetic transformation to swap DNA with neighbors, allowing it to evade our immune system’s best defenses.

Neisseria meningitidis, or the meningococcus, is a Gram-negative diplococcus that exclusively colonizes humans. While up to 25% of adults carry the bacteria in their nasopharynx without symptoms, it can occasionally invade the bloodstream. Once inside, it utilizes virulence factors like pili for adhesion and a polysaccharide capsule to avoid phagocytosis. The bacterium is uniquely adapted to the human host, specifically requiring iron from human transferrin and lactoferrin to survive, which explains why it has never been isolated from other animals.

The pathogen’s ability to cause disease is driven by its extreme genetic plasticity. Through a process called natural competence, it takes up foreign DNA from neighboring cells and integrates it into its own genome. This mechanism is particularly active in genes involved in DNA repair, likely helping the bacteria survive the oxidative stress encountered within the human nasopharynx. This constant horizontal gene transfer allows for rapid evolution, including the emergence of hypervirulent strains that can switch capsule types to hide from the host's immune system.

Clinical presentation is often non-specific, starting with fever and headache, but can progress to life-threatening sepsis or meningitis within hours. A hallmark of meningococcal septicaemia is a non-blanching purpuric rash, which serves as a critical warning sign. Because the disease moves so quickly, medical guidance emphasizes immediate antibiotic administration upon suspicion, even before laboratory confirmation. While vaccines targeting specific serogroups like A, B, C, W, and Y have significantly reduced incidence in many regions, the bacterium's diverse antigenic structure and ability to evolve continue to challenge the development of a universal vaccine.

Beyond its role as a pathogen, N. meningitidis has become a valuable tool in biotechnology. Its Cas9 enzyme is utilized in CRISPR gene editing due to its compact size and distinct targeting capabilities. Additionally, its FrpC protein has been engineered for precise protein coupling, demonstrating how the same mechanisms that allow this bacterium to thrive in the human body can be repurposed for scientific advancement.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/gardening-neisseria-meningitidis.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…